Navarro-Ramirez R, Lang G, Moriguchi Y, Elowitz E, Corredor JAlfredo, Avila MJ, Gotfryd A, Alimi M, Gandevia L, Härtl R.
2017.
Are Locked Facets a Contraindication for Extreme Lateral Interbody Fusion? World Neurosurg. 100:607-618.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Lang G, Navarro-Ramirez R, Gandevia L, Hussain I, Nakhla J, Zubkov M, Härtl R.
2017.
Elimination of Subsidence with 26-mm-Wide Cages in Extreme Lateral Interbody Fusion.. World Neurosurg. 104:644-652.
Dhandapani S, Singh H, Negm HM, Cohen S, Souweidane MM, Greenfield JP, Anand VK, Schwartz TH.
2017.
Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.. J Neurosurg. 126(2):418-430.
Patrona A, Patel KS, Bander ED, Mehta A, Tsiouris AJohn, Anand VK, Schwartz TH.
2017.
Endoscopic endonasal surgery for nonadenomatous, nonmeningeal pathology involving the cavernous sinus.. J Neurosurg. 126(3):880-888.
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al..
2017.
Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.